Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey L Bonfield

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Clinics in Chest Medicine|February 10, 2016
Innate and Adaptive Immunity in Cystic FibrosisEmanuela M Bruscia, Tracey L Bonfield
Journal of Innate Immunity|June 24, 2016
Cystic Fibrosis Lung Immunity: The Role of the MacrophageEmanuela M Bruscia, Tracey L Bonfield
Plos One|September 9, 2017
Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophagesChristopher R Nitkin, Tracey L Bonfield
Discovery Medicine|April 29, 2010
Adult mesenchymal stem cells: an innovative therapeutic for lung diseasesTracey L Bonfield, Arnold I Caplan
Stem Cells International|August 15, 2014
Stem cells: innovations in clinical applicationsMorgan T Sutton, Tracey L Bonfield
Stem Cells Translational Medicine|February 14, 2017
Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential ImprovementsChristopher R Nitkin, Tracey L Bonfield
Current Opinion in Allergy and Clinical Immunology|December 24, 2011
Asthma heterogeneity and therapeutic options from the clinic to the benchTracey L Bonfield, Kristie R Ross
Best Practice & Research. Clinical Haematology|April 24, 2025
Human mesenchymal stem cell therapy: Potential advances for reducing cystic fibrosis infection and organ inflammationTracey L Bonfield, Hillard M Lazarus
Clinics in Chest Medicine|November 7, 2022
Update on Innate and Adaptive Immunity in Cystic FibrosisEmanuela M Bruscia, Tracey L Bonfield
Journal of Inflammation (London, England)|October 14, 2011
Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cellsAicha Saadane, Jean Eastman, Melvin Berger, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Clinics in Chest Medicine|February 10, 2016
Innate and Adaptive Immunity in Cystic FibrosisEmanuela M Bruscia, Tracey L Bonfield
Journal of Innate Immunity|June 24, 2016
Cystic Fibrosis Lung Immunity: The Role of the MacrophageEmanuela M Bruscia, Tracey L Bonfield
Plos One|September 9, 2017
Balancing anti-inflammatory and anti-oxidant responses in murine bone marrow derived macrophagesChristopher R Nitkin, Tracey L Bonfield
Discovery Medicine|April 29, 2010
Adult mesenchymal stem cells: an innovative therapeutic for lung diseasesTracey L Bonfield, Arnold I Caplan
Stem Cells International|August 15, 2014
Stem cells: innovations in clinical applicationsMorgan T Sutton, Tracey L Bonfield
Stem Cells Translational Medicine|February 14, 2017
Concise Review: Mesenchymal Stem Cell Therapy for Pediatric Disease: Perspectives on Success and Potential ImprovementsChristopher R Nitkin, Tracey L Bonfield
Current Opinion in Allergy and Clinical Immunology|December 24, 2011
Asthma heterogeneity and therapeutic options from the clinic to the benchTracey L Bonfield, Kristie R Ross
Best Practice & Research. Clinical Haematology|April 24, 2025
Human mesenchymal stem cell therapy: Potential advances for reducing cystic fibrosis infection and organ inflammationTracey L Bonfield, Hillard M Lazarus
Clinics in Chest Medicine|November 7, 2022
Update on Innate and Adaptive Immunity in Cystic FibrosisEmanuela M Bruscia, Tracey L Bonfield
Journal of Inflammation (London, England)|October 14, 2011
Parthenolide inhibits ERK and AP-1 which are dysregulated and contribute to excessive IL-8 expression and secretion in cystic fibrosis cellsAicha Saadane, Jean Eastman, Melvin Berger, et al.
Pageof 7